{
    "other_tests": [
        {
            "procedure_name": "Exhaled Carbon Monoxide Test",
            "date": "Not specified",
            "findings": "Initial exhaled carbon monoxide level was 21 ppm; post-relapse level was 25 ppm.",
            "changes_over_time": "Reduced carbon monoxide levels were observed over the next year after several quit attempts."
        },
        {
            "procedure_name": "Serum Blood Nicotine and Cotinine Levels Test",
            "date": "Not specified",
            "findings": "Serum blood nicotine level was 28 ng/ml and cotinine level was 337 ng/ml.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Nicotine Nasal Spray Usage",
            "date": "Started treatment in the next year after initial visit",
            "findings": "Preferred nicotine nasal spray with 40 doses per day, consuming significant amounts exceeding recommended limits.",
            "changes_over_time": "Reported no nicotine toxicity or symptoms, but increased attempts to quit were observed over an 18-month period."
        },
        {
            "procedure_name": "Follow-up Visits to Tobacco Program",
            "date": "As of 2006",
            "findings": "Expired carbon monoxide readings consistently less than 3 ppm, confirming smoking abstinence.",
            "changes_over_time": "Significant improvements in mental status and functioning noted since 2003."
        },
        {
            "procedure_name": "Monitoring of Nasal Mucosa",
            "date": "Not specified",
            "findings": "Evaluation was normal after long-term use of nicotine nasal spray.",
            "changes_over_time": "Not specified"
        }
    ]
}